These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 8588611

  • 21. Evaluation of retrosigmoid vestibular neurectomy for intractable vertigo in Ménière's disease: an interdisciplinary review.
    Li CS, Lai JT.
    Acta Neurochir (Wien); 2008 Jul; 150(7):655-61; discussion 661. PubMed ID: 18536995
    [Abstract] [Full Text] [Related]

  • 22. Factors influencing results with streptomycin perfusion of the labyrinth.
    Shea JJ, Ge X.
    Am J Otol; 1993 Nov; 14(6):570-5. PubMed ID: 8296861
    [Abstract] [Full Text] [Related]

  • 23. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS, Sánchez-Ferrandiz N, Guillén-Grima F, Perez N.
    Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
    [Abstract] [Full Text] [Related]

  • 24. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.
    Lange G, Maurer J, Mann W.
    Laryngoscope; 2004 Jan; 114(1):102-5. PubMed ID: 14710003
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of quality of life after intratympanic streptomycin injection in patients with Ménière's disease.
    Jung J, Chun J, Kim N, Kim Y, Lee WS.
    Otol Neurotol; 2008 Sep; 29(6):816-23. PubMed ID: 18617871
    [Abstract] [Full Text] [Related]

  • 26. Titration streptomycin therapy for bilateral Meniére's disease. Follow-up report.
    Langman AW, Kemink JL, Graham MD.
    Ann Otol Rhinol Laryngol; 1990 Nov; 99(11):923-6. PubMed ID: 2241020
    [Abstract] [Full Text] [Related]

  • 27. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M, Kitahara T, Fukushima M, Nakagawa A, Masumura C, Sasaki T, Kizawa K, Kubo T.
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [Abstract] [Full Text] [Related]

  • 28. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
    Garduño-Anaya MA, Couthino De Toledo H, Hinojosa-González R, Pane-Pianese C, Ríos-Castañeda LC.
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
    [Abstract] [Full Text] [Related]

  • 29. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
    Smith WK, Sandooram D, Prinsley PR.
    J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921
    [Abstract] [Full Text] [Related]

  • 30. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
    Helling K, Schönfeld U, Clarke AH.
    Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448
    [Abstract] [Full Text] [Related]

  • 31. Low dose transtympanic gentamicin treatment for intractable Meniere's disease: a prospective study.
    Kasemsuwan L, Jariengprasert C, Ruencharopen S, Orathai P.
    J Med Assoc Thai; 2007 Feb; 90(2):327-34. PubMed ID: 17375639
    [Abstract] [Full Text] [Related]

  • 32. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
    Akkuzu B, Ozgirgin N, Ozlüoğlu LN.
    Kulak Burun Bogaz Ihtis Derg; 2006 Feb; 16(5):193-9. PubMed ID: 17124437
    [Abstract] [Full Text] [Related]

  • 33. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D, Wolf M, Kronenberg J.
    Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
    [Abstract] [Full Text] [Related]

  • 34. Low-dose intratympanic gentamicin treatment for dizziness in Ménière's disease.
    Longridge NS, Mallinson AI.
    J Otolaryngol; 2000 Feb; 29(1):35-9. PubMed ID: 10709170
    [Abstract] [Full Text] [Related]

  • 35. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C, Franco-Vidal V, Bebear JP, Darrouzet V.
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [Abstract] [Full Text] [Related]

  • 36. [Long-term results of gentamycin therapy of Menière's disease].
    Blessing RE, Schlenter WW.
    Laryngorhinootologie; 1989 Dec; 68(12):657-60. PubMed ID: 2610793
    [Abstract] [Full Text] [Related]

  • 37. Long-term results of endolymphatic mastoid shunt surgery in patients with intractable Ménière's disease.
    Yu MS, Lee KS, Chung JW.
    Otolaryngol Head Neck Surg; 2009 Aug; 141(2):237-42. PubMed ID: 19643258
    [Abstract] [Full Text] [Related]

  • 38. Vestibular neurectomy vs. chemical labyrinthectomy in the treatment of disabling Menière's disease: a long-term comparative study.
    Schmerber S, Dumas G, Morel N, Chahine K, Karkas A.
    Auris Nasus Larynx; 2009 Aug; 36(4):400-5. PubMed ID: 19026499
    [Abstract] [Full Text] [Related]

  • 39. Comparison of long-term hearing results after vestibular neurectomy, endolymphatic mastoid shunt, and medical therapy.
    Quaranta A, Onofri M, Sallustio V, Iurato S.
    Am J Otol; 1997 Jul; 18(4):444-8. PubMed ID: 9233483
    [Abstract] [Full Text] [Related]

  • 40. Transtympanic gentamicin treatment using Silverstein MicroWick in Ménière's disease patients: long term outcome.
    Suryanarayanan R, Srinivasan VR, O'Sullivan G.
    J Laryngol Otol; 2009 Jan; 123(1):45-9. PubMed ID: 18533050
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.